Børre Fevang

2.8k total citations
56 papers, 1.1k citations indexed

About

Børre Fevang is a scholar working on Immunology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Børre Fevang has authored 56 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Immunology, 11 papers in Genetics and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Børre Fevang's work include Immunodeficiency and Autoimmune Disorders (33 papers), Immune Cell Function and Interaction (20 papers) and Blood disorders and treatments (9 papers). Børre Fevang is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (33 papers), Immune Cell Function and Interaction (20 papers) and Blood disorders and treatments (9 papers). Børre Fevang collaborates with scholars based in Norway, United States and Denmark. Børre Fevang's co-authors include Pål Aukrust, Silje F. Jørgensen, Stig S. Frøland, Arne Yndestad, Bente Halvorsen, Are Martin Holm, Thor Ueland, Jan Kristian Damås, Wiggo J. Sandberg and S S Frøland and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Børre Fevang

54 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Børre Fevang Norway 20 739 199 199 188 154 56 1.1k
Yumiko Sato Japan 17 481 0.7× 156 0.8× 102 0.5× 139 0.7× 208 1.4× 122 1.6k
I J ten Berge Netherlands 15 724 1.0× 228 1.1× 106 0.5× 330 1.8× 192 1.2× 19 1.5k
Manfred Hoenig Germany 16 609 0.8× 90 0.5× 248 1.2× 100 0.5× 126 0.8× 33 924
Tiphanie P. Vogel United States 13 612 0.8× 101 0.5× 153 0.8× 105 0.6× 133 0.9× 43 1.1k
Darryl Maher Australia 13 720 1.0× 276 1.4× 121 0.6× 179 1.0× 324 2.1× 23 1.3k
Avinash Khandagale Sweden 10 606 0.8× 162 0.8× 119 0.6× 186 1.0× 59 0.4× 14 1.1k
Tsuyoshi Takahashi Japan 19 439 0.6× 121 0.6× 81 0.4× 191 1.0× 252 1.6× 72 1.1k
Marie Rimbert France 15 772 1.0× 165 0.8× 53 0.3× 170 0.9× 293 1.9× 32 1.1k
Efrem Eren United Kingdom 12 613 0.8× 69 0.3× 122 0.6× 110 0.6× 73 0.5× 26 908
Sarita Workman United Kingdom 18 497 0.7× 156 0.8× 125 0.6× 155 0.8× 35 0.2× 28 677

Countries citing papers authored by Børre Fevang

Since Specialization
Citations

This map shows the geographic impact of Børre Fevang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Børre Fevang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Børre Fevang more than expected).

Fields of papers citing papers by Børre Fevang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Børre Fevang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Børre Fevang. The network helps show where Børre Fevang may publish in the future.

Co-authorship network of co-authors of Børre Fevang

This figure shows the co-authorship network connecting the top 25 collaborators of Børre Fevang. A scholar is included among the top collaborators of Børre Fevang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Børre Fevang. Børre Fevang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Mingyi, Mari Kaarbø, Henrik M. Reims, et al.. (2024). Altered Genome-Wide DNA Methylation in the Duodenum of Common Variable Immunodeficiency Patients. Journal of Clinical Immunology. 44(6). 133–133. 1 indexed citations
2.
Skudal, Hilde, Åslaug Rudjord Lorentzen, Tore Stenstad, et al.. (2024). Clinical characteristics and factors affecting disease severity in hospitalized tick-borne encephalitis patients in Norway from 2018 to 2022. European Journal of Clinical Microbiology & Infectious Diseases. 43(7). 1355–1366. 4 indexed citations
3.
Reims, Henrik M., Børre Fevang, Espen Melum, et al.. (2023). Long-term survival after liver transplantation in patients with common variable immunodeficiency. Liver Transplantation. 29(8). 894–899. 2 indexed citations
4.
Fevang, Børre, et al.. (2023). Cellular immunity in COVID-19 and other infections in Common variable immunodeficiency. Frontiers in Immunology. 14. 1124279–1124279. 4 indexed citations
5.
Hov, Johannes R., Trine Ranheim, Beate Vestad, et al.. (2023). Increased Plasma Levels of Triglyceride-Enriched Lipoproteins Associate with Systemic Inflammation, Lipopolysaccharides, and Gut Dysbiosis in Common Variable Immunodeficiency. Journal of Clinical Immunology. 43(6). 1229–1240. 9 indexed citations
6.
Fevang, Børre. (2023). Treatment of inflammatory complications in common variable immunodeficiency (CVID): current concepts and future perspectives. Expert Review of Clinical Immunology. 19(6). 627–638. 17 indexed citations
7.
Hov, Johannes R., Xiang Yi Kong, Pavol Bohov, et al.. (2021). Altered Plasma Fatty Acids Associate with Gut Microbial Composition in Common Variable Immunodeficiency. Journal of Clinical Immunology. 42(1). 146–157. 9 indexed citations
8.
Jørgensen, Silje F., Jochen Buechner, Anders Eivind Myhre, et al.. (2021). A Nationwide Study of GATA2 Deficiency in Norway—the Majority of Patients Have Undergone Allo-HSCT. Journal of Clinical Immunology. 42(2). 404–420. 10 indexed citations
9.
Hov, Johannes R., Thor Ueland, Tuva B. Dahl, et al.. (2020). Gut Microbiota-Dependent Trimethylamine N-Oxide Associates With Inflammation in Common Variable Immunodeficiency. Frontiers in Immunology. 11. 574500–574500. 42 indexed citations
10.
Holmøy, Trygve, Børre Fevang, David B. Olsen, Olav Spigset, & Lars Bø. (2019). Adverse events with fatal outcome associated with alemtuzumab treatment in multiple sclerosis. BMC Research Notes. 12(1). 497–497. 37 indexed citations
11.
Otterdal, Kari, Åse Berg, Annika E. Michelsen, et al.. (2018). Soluble markers of neutrophil, T-cell and monocyte activation are associated with disease severity and parasitemia in falciparum malaria. BMC Infectious Diseases. 18(1). 670–670. 22 indexed citations
12.
Jørgensen, Silje F., Børre Fevang, & Pål Aukrust. (2018). Autoimmunity and Inflammation in CVID: a Possible Crosstalk between Immune Activation, Gut Microbiota, and Epigenetic Modifications. Journal of Clinical Immunology. 39(1). 30–36. 42 indexed citations
13.
14.
Holm, Are Martin, Børre Fevang, Thor Ueland, et al.. (2013). Lung disease, T-cells and inflammation in common variable immunodeficiency disorders. Scandinavian Journal of Clinical and Laboratory Investigation. 73(6). 514–522. 10 indexed citations
15.
Halvorsen, Bente, Isabelle Daissormont, Trine Ranheim, et al.. (2012). Increased levels of the homeostatic chemokine CXCL13 in human atherosclerosis – Potential role in plaque stabilization. Atherosclerosis. 224(1). 266–273. 30 indexed citations
16.
Landrø, Linn, Jan Kristian Damås, Bente Halvorsen, et al.. (2009). CXCL16 in HIV infection – a link between inflammation and viral replication. European Journal of Clinical Investigation. 39(11). 1017–1024. 11 indexed citations
17.
Fevang, Børre, Jesper Eugen‐Olsen, Arne Yndestad, et al.. (2009). Enhanced levels of urokinase plasminogen activator and its soluble receptor in common variable immunodeficiency. Clinical Immunology. 131(3). 438–446. 12 indexed citations
18.
Dahl, Christen P., Lars Gullestad, Børre Fevang, et al.. (2008). Increased Expression of LIGHT/TNFSF14 and its Receptors in Experimental and Clinical Heart Failure. European Journal of Heart Failure. 10(4). 352–359. 28 indexed citations
19.
Damås, Jan Kristian, Linn Landrø, Børre Fevang, et al.. (2008). Enhanced levels of the CCR7 ligands CCL19 and CCL21 in HIV infection: correlation with viral load, disease progression and response to highly active antiretroviral therapy. AIDS. 23(1). 135–138. 18 indexed citations
20.
Smith, Camilla, Bente Halvorsen, Kari Otterdal, et al.. (2008). High levels and inflammatory effects of soluble CXC ligand 16 (CXCL16) in coronary artery disease: down-regulatory effects of statins. Cardiovascular Research. 79(1). 195–203. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yumiko Sato Breakdown of academic impact, for papers by I J ten Berge Breakdown of academic impact, for papers by Manfred Hoenig Breakdown of academic impact, for papers by Tiphanie P. Vogel Breakdown of academic impact, for papers by Darryl Maher Breakdown of academic impact, for papers by Avinash Khandagale Breakdown of academic impact, for papers by Tsuyoshi Takahashi Breakdown of academic impact, for papers by Marie Rimbert Breakdown of academic impact, for papers by Efrem Eren Breakdown of academic impact, for papers by Sarita Workman
Rankless by CCL
2026